Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | MAP3K9 | P80192 | 3/20 | 0.35 |
| ▸ | MAP3K11 | Q16584 | 3/20 | 0.35 |
| ▸ | CDK4 | P11802 | 1/20 | 0.35 |
| ▸ | CCND1 | P24385 | 1/20 | 0.35 |
| ▸ | TNKS | O95271 | 1/20 | 0.35 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.33 |
| ▸ | MAP3K10 | Q02779 | 1/20 | 0.33 |
| ▸ | KIF11 | P52732 | 1/20 | 0.32 |
| ▸ | BCHE | P06276 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21709326 | 0.87 | MEN1 (0.40) | MEN1MAPTRAB9AKMT2AMAP3K9 | |
| SCHEMBL15860309 | 0.85 | KIF11 (0.43) | KIF11BCHE | |
| SCHEMBL20175466 | 0.82 | ALOX5 (0.37) | ALOX5 | |
| SCHEMBL20175558 | 0.82 | ALOX5 (0.34) | ALOX5 | |
| SCHEMBL20175572 | 0.80 | KDM4E (0.36) | MAPTALOX5 | |
| SCHEMBL10165697 | 0.80 | ALOX5 (0.52) | MAPTTNKSTNKS2ALOX5 | |
| SCHEMBL20175561 | 0.80 | PDE6D (0.33) | ALOX5 | |
| SCHEMBL21942543 | 0.80 | TNKS (0.38) | MEN1MAPTRAB9AKMT2AMAP3K9 | |
| SCHEMBL20175573 | 0.79 | PMM2 (0.33) | ALOX5 | |
| SCHEMBL20175514 | 0.79 | ALOX5 (0.39) | MAPTTNKSTNKS2ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230240141-A1 | ORGANIC ELECTRONIC ELEMENT COMPRISING COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-07-27 | — | — | US | disclosed |
| WO-2021230650-A1 | ORGANIC ELECTRONIC ELEMENT COMPRISING COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE THEREOF | 덕산네오룩스 주식회사 | 2021-11-18 | — | — | WO | disclosed |
| WO-2020032447-A1 | ORGANIC ELECTRONIC ELEMENT COMPRISING, AS HOST MATERIAL, MIXTURE OF DIFFERENT KINDS OF COMPOUNDS, AND ELECTRONIC DEVICE THEREOF | 덕산네오룩스 주식회사 | 2020-02-13 | — | — | WO | disclosed |
| WO-2020032424-A1 | ORGANIC ELECTRONIC ELEMENT COMPRISING, AS HOST MATERIAL, MIXTURE OF DIFFERENT KINDS OF COMPOUNDS, AND ELECTRONIC DEVICE THEREOF | 덕산네오룩스 주식회사 | 2020-02-13 | — | — | WO | disclosed |
| WO-2020032428-A1 | ORGANIC ELECTRIC ELEMENT COMPRISING COMPOUND FOR ORGANIC ELECTRIC ELEMENT AND ELECTRONIC DEVICE USING SAME | 덕산네오룩스 주식회사 | 2020-02-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230240141-A1 | ORGANIC ELECTRONIC ELEMENT COMPRISING COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE THEREOF | ESR1, GPX1, LEF1 | MEN1 652/4885MAPT 1456/4885RAB9A 1729/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.